WASHINGTON - On Tuesday, U.S. officials recommended a "pause" on the use of the Johnson & Johnson COVID-19 vaccine in order to investigate U.S. reports of a rare type of blood clot following ...

SAN FRANCISCO (KGO) -- A one-dose COVID-19 vaccine has been given the green light to resume. The CDC and FDA said Saturday Johnson and Johnson vaccinations can resume immediately, after being halted ...

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

The Johnson & Johnson COVID-19 vaccine is now the third approved for emergency use authorization in the United States, and it's a little different from its predecessors. SciShow is supported by ...

Johnson & Johnson announced Monday it could have a coronavirus vaccine ready for human testing by September. The company said it has selected a lead vaccine candidate from constructs it's been working ...

Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.

NEW YORK (WABC) -- Johnson & Johnson got the green light from federal officials to resume administering their vaccine just over a week after it was paused. The CDC determined the benefits of the ...

DETROIT -- Detroit Mayor Mike Duggan declined an initial allocation of the newly authorized Johnson & Johnson COVID-19 vaccine this week even as nationwide demand continues to outpace available supply ...